Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Brown

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Contraception|December 21, 2020
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting systemTomiko Sunaga, Brian Cicali, Stephan Schmidt, et al.
Journal of Managed Care & Specialty Pharmacy|May 28, 2016
Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims DataNathan J Pauly, Jeffery C Talbert, Joshua Brown
JAMA Surgery|August 21, 2024
Fresh Frozen Plasma to Red Blood Cell Ratios and Survival BenefitJason L Sperry, Christine M Leeper, Joshua Brown
Journal of Molecular Graphics & Modelling|April 26, 2016
CTViz: A tool for the visualization of transport in nanocompositesBenjamin Beach, Joshua Brown, Taylor Tarlton, et al.
The Lancet. Haematology|December 19, 2018
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysisGhadeer K Dawwas, Joshua Brown, Eric Dietrich, et al.
The Lancet. Haematology|March 31, 2019
Can apixaban prevent venous thromboembolism better than rivaroxaban? - Authors' replyGhadeer K Dawwas, Joshua Brown, Eric Dietrich, et al.
Healthcare (Basel, Switzerland)|October 17, 2020
Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia PatientsPhuong T Tran, William B Slayton, Mansi Dalal, et al.
Patient Safety in Surgery|March 22, 2018
Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinicJoshua Brown, Jeffery Talbert, Ryan Pennington, et al.
Frontiers in Robotics and AI|October 3, 2022
Design, characterisation and validation of a haptic interface based on twisted string actuationValeria Skvortsova, Simeon Nedelchev, Joshua Brown, et al.
The Annals of Pharmacotherapy|December 11, 2023
Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake InhibitorsRaj Desai, Steven M Smith, Rajesh Mohandas, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Contraception|December 21, 2020
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting systemTomiko Sunaga, Brian Cicali, Stephan Schmidt, et al.
Journal of Managed Care & Specialty Pharmacy|May 28, 2016
Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims DataNathan J Pauly, Jeffery C Talbert, Joshua Brown
JAMA Surgery|August 21, 2024
Fresh Frozen Plasma to Red Blood Cell Ratios and Survival BenefitJason L Sperry, Christine M Leeper, Joshua Brown
Journal of Molecular Graphics & Modelling|April 26, 2016
CTViz: A tool for the visualization of transport in nanocompositesBenjamin Beach, Joshua Brown, Taylor Tarlton, et al.
The Lancet. Haematology|December 19, 2018
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysisGhadeer K Dawwas, Joshua Brown, Eric Dietrich, et al.
The Lancet. Haematology|March 31, 2019
Can apixaban prevent venous thromboembolism better than rivaroxaban? - Authors' replyGhadeer K Dawwas, Joshua Brown, Eric Dietrich, et al.
Healthcare (Basel, Switzerland)|October 17, 2020
Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia PatientsPhuong T Tran, William B Slayton, Mansi Dalal, et al.
Patient Safety in Surgery|March 22, 2018
Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinicJoshua Brown, Jeffery Talbert, Ryan Pennington, et al.
Frontiers in Robotics and AI|October 3, 2022
Design, characterisation and validation of a haptic interface based on twisted string actuationValeria Skvortsova, Simeon Nedelchev, Joshua Brown, et al.
The Annals of Pharmacotherapy|December 11, 2023
Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake InhibitorsRaj Desai, Steven M Smith, Rajesh Mohandas, et al.
Pageof 10